Do not lose sight of:
Food and Drug Administration: Study medication NNZ-2566 used in Rett Syndrome
1) My daughter, Chelsea Lauran Parris, age 27, has Rett Syndrome. She is a participant in the safety double blind study of NNZ-2566. This study is med vs placebo. She took a low dose of 35.5mg/kg twice a day. After her starting dose of 10mg/kg she went over 2 minutes at a time for over an hour without wringing her hands (which is a trait of Rett Syndrome). She became more attentive, used her right hand purposefully (which she has never done), started making babbling vocalizations, and her body became less rigid. She has always been severely constipated and that ended also with us being able to get a bowel regime going. She was on her medication for 14 days. We saw no negative side effects from her medication. 36 hours after going off her medication, her hand wringing resumed with great intensity. She became rigid again. Her babbling decreased. Her eye contact went back to the way it was before. I would like for the FDA to consider making NNZ available so my daughter and others with Rett Syndrome may start receiving it. We do not know, nor do the doctors or any members of the research team know if Chelsea had the med, NNZ or a placebo. I feel like she had the medication and not a placebo I would like for her to have the opportunity to take a larger dose and improve her quality of life. I am requesting that this medication trial be opened very quickly. That all Rett Syndrome females be given the opportunity to receive NNZ.
2) alert while walking independently, which he did for several years. His general health improved. Stamina, walking, seizures all improved, while the NNZ drug. After a few days of not coming out NNZ my daughter went right back to all her problems. Is having seizures, head is hanging back, she did not want to walk without the full support from me, his general state of health has declined and went back to the way it was before taking NNZ. Please listen to our voices for our girls who can not speak for themselves. This has the potential to really make a global difference for all of our girls / women.
- Forums
- ASX - By Stock
- NEU
- dr. mike snape video
dr. mike snape video, page-22
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$16.57 |
Change
2.170(15.1%) |
Mkt cap ! $2.117B |
Open | High | Low | Value | Volume |
$14.85 | $16.67 | $14.60 | $24.77M | 1.544M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | $16.52 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$16.57 | 1717 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 250 | 16.480 |
1 | 300 | 16.470 |
1 | 500 | 16.400 |
1 | 3 | 16.270 |
1 | 150 | 16.200 |
Price($) | Vol. | No. |
---|---|---|
16.570 | 1717 | 1 |
16.600 | 2001 | 1 |
16.620 | 2306 | 2 |
16.650 | 2000 | 1 |
16.660 | 250 | 1 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online